As reported extensively on the Health Business Blog (see here, here, here, here, here, here, and here ) Genentech has undergone a contentious period with the American Academy of Ophthalmology (AAO) and American Society of Retina Specialists (ASRS). Compounding pharmacies have been repackaging Avastin into small doses, which eye doctors then use in […]
Continued Read ...
The transcript of the recent podcast interview with Alan Eisenberg is posted at the Health Business Blog.
Read more this great post here
Continued Read ...
Fred Fortin
I interviewed Genentech spokeswoman Dawn Kalmar today to get some more details on the company’s decision to stop distributing Avastin to compounding pharmacies. For background please see my prior posts: Avastin update: Still seeking answers and Latest developments in the Avastin/Lucentis saga raise new questions.
In summary:
In its inspection of Genentech’s manufacturing site, […]
Continued Read ...
David Williams
Since the early 1980s, the Federal Government has provided Small Business Innovation Research –or SBIR—grants to fund research and development projects. In 2003, the Small Business Administration ruled that companies that were majority owned by venture capital firms would no longer be eligible for such funding.
The biotech industry and its supporters complained […]
Continued Read ...
